In patients with APS who are taking vitamin K antagonists and have increased values of aCL, aβ2GPI and LAC, it is not recommended to monitor the value of the INR determined by the POCT device, especially if the INR is > 3.0. The gene discussed is LCT; the disease is autoimmune polyendocrinopathy.